Regulation of Hepatitis B Virus Capsid Assembly
乙型肝炎病毒衣壳组装的调控
基本信息
- 批准号:9213611
- 负责人:
- 金额:$ 37.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-23 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsArginineBacteriaBindingC-PeptideC-terminalCDK2 geneCapsidCapsid ProteinsCell ExtractsCell-Free SystemCellsChronic viral hepatitisCirrhosisComplexCyclinsDNADNA BindingDNA VirusesDevelopmentGenomeHepatitisHepatitis B VirusIn VitroInsectaIntegration Host FactorsLife Cycle StagesLiver CirrhosisLiver diseasesMalignant neoplasm of liverMammalian CellMediatingMethodsN-terminalNucleocapsidOryctolagus cuniculusPeptidesPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysiologicalPlayProcessProtaminesProtein DephosphorylationProtein KinaseProtein phosphataseProteinsRNARNA BindingRNA-Directed DNA PolymeraseReactionRegulationReticulocytesReverse TranscriptionRiskRoleStagingSystemViralViral PackagingViral ProteinsViral Reverse TranscriptionVirionVirusVirus AssemblyVirus DiseasesVirus Replicationabstractingbasechronic liver diseaseinsightnoveloverexpressionpathogenprotein protein interactionvirus core
项目摘要
Abstract
Hepatitis B virus (HBV) is a major cause of chronic viral hepatitis that increases dramatically the risk of liver
cancer and other end-stage liver diseases such as cirrhosis. HBV is a small DNA virus and replicates its DNA
genome via reverse transcription of a RNA intermediate called the pregenomic RNA (pgRNA). Viral replication
depends critically on the assembly of a nucleocapsid (NC) that is composed of the viral core or capsids protein
(HBc) and encapsidates a copy each of pgRNA and the reverse transcriptase (RT), which converts the RNA
pregenome to the DNA genome within the NC. Viral capsids also encapsidate the host cyclin-dependent
kinase 2 (CDK2) via unknown mechanisms. Challenging the current dogma that capsid assembly depends
solely on the N-terminal domain (NTD) of HBc, we have recently discovered that under physiological
conditions, capsid assembly critically depends on the C-terminal domain (CTD) of HBc. Furthermore, we have
developed a mammalian cell-free system that recapitulates CTD-dependent capsid assembly and further
regulates capsid assembly through host-mediated CTD phosphorylation and dephosphorylation. The cell-free
capsid assembly system also recapitulates the specific encapsidation of CDK2. Building on these
developments, we propose to dissect the role of CTD, and its state of phosphorylation as regulated by cellular
protein kinases and phosphatases, in capsid assembly (Specific Aim 1). We also plan to elucidate the HBc and
CDK2 requirements for CDK2 encapsidation (Specific Aim 2). Furthermore, we have recently developed
methods to isolate the viral pgRNA in complex with RT, which is the substrate recognized by HBc during NC
assembly to achieve specific encapsidation of pgRNA and RT. We now propose to combine the isolation of the
pgRNA-RT complex together with the cell-free capsid assembly system to develop cell-free systems for the
specific packaging of pgRNA (and RT) into NCs (Specific Aim 3).
摘要
乙肝病毒(乙肝病毒)是慢性病毒性肝炎的主要原因,它极大地增加了患肝脏的风险
癌症和其他终末期肝病,如肝硬变。乙肝病毒是一种小的DNA病毒,可以复制它的DNA
通过逆转录一种称为前基因组RNA(PgRNA)的RNA中间体来获得基因组。病毒复制
关键依赖于由病毒核心或衣壳蛋白组成的核衣壳(NC)的组装
(HBC),并封装pgRNA和逆转录酶(RT)的每个副本,逆转录酶(RT)转换RNA
前基因组到NC内的DNA基因组。病毒衣壳还包裹依赖于细胞周期蛋白的宿主
激酶2(CDK2)通过未知的机制被激活。挑战当前的教条,即船体组装依赖于
仅在HBC的N-末端结构域(NTD)上,我们最近发现在生理条件下
条件,衣壳组装关键取决于HBC的C-末端结构域(CTD)。此外,我们还拥有
开发了一种哺乳动物无细胞系统,它概括了依赖CTD的衣壳组装,并进一步
通过宿主介导的CTD磷酸化和去磷酸化来调节衣壳组装。无细胞的
衣壳组装系统还概括了CDK2的特异性包裹。建立在这些基础上
发展,我们建议剖析ctd的作用,以及它受细胞调控的磷酸化状态。
衣壳组装中的蛋白激酶和磷酸酶(特定目标1)。我们还计划澄清HBC和
对CDK2封装的要求(具体目标2)。此外,我们最近开发了一种
方法分离病毒pgRNA与RT的复合体,RT是NC过程中HBC识别的底物
组装以实现pgRNA和RT的特异性封装。我们现在建议将隔离
PgRNA-RT复合体与无细胞衣壳组装系统共同开发无细胞系统
将pgRNA(和RT)特定包装成NCS(特定目标3)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jianming Hu其他文献
Jianming Hu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jianming Hu', 18)}}的其他基金
Regulation of Hepatitis B Virus Capsid Assembly
乙型肝炎病毒衣壳组装的调控
- 批准号:
9761828 - 财政年份:2016
- 资助金额:
$ 37.88万 - 项目类别:
Regulation of Hepatitis B Virus Capsid Assembly
乙型肝炎病毒衣壳组装的调控
- 批准号:
9357504 - 财政年份:2016
- 资助金额:
$ 37.88万 - 项目类别:
REVERSE TRANSCRIPTION-ASSOCIATED DEPHOSPHORYLATION OF HEPADNAVIRUS NUCLEOCAPSID
反转录相关的肝炎病毒核衣壳去磷酸化
- 批准号:
8365503 - 财政年份:2011
- 资助金额:
$ 37.88万 - 项目类别:
REVERSE TRANSCRIPTION-ASSOCIATED DEPHOSPHORYLATION OF HEPADNAVIRUS NUCLEOCAPSID
反转录相关的肝炎病毒核衣壳去磷酸化
- 批准号:
8170867 - 财政年份:2010
- 资助金额:
$ 37.88万 - 项目类别:
REVERSE TRANSCRIPTION-ASSOCIATED DEPHOSPHORYLATION OF HEPADNAVIRUS NUCLEOCAPSID
反转录相关的肝炎病毒核衣壳去磷酸化
- 批准号:
7955892 - 财政年份:2009
- 资助金额:
$ 37.88万 - 项目类别:
REVERSE TRANSCRIPTION-ASSOCIATED DEPHOSPHORYLATION OF HEPADNAVIRUS NUCLEOCAPSID
反转录相关的肝炎病毒核衣壳去磷酸化
- 批准号:
7722968 - 财政年份:2008
- 资助金额:
$ 37.88万 - 项目类别:
Molecular Mechanism of Hepadnavirus Persistence
嗜肝DNA病毒持久性的分子机制
- 批准号:
7462996 - 财政年份:2008
- 资助金额:
$ 37.88万 - 项目类别:
Molecular Mechanism of Hepadnavirus Persistence
嗜肝DNA病毒持久性的分子机制
- 批准号:
7777354 - 财政年份:2008
- 资助金额:
$ 37.88万 - 项目类别:
Molecular Mechanism of Hepadnavirus Persistence
嗜肝DNA病毒持久性的分子机制
- 批准号:
7569354 - 财政年份:2008
- 资助金额:
$ 37.88万 - 项目类别:
Molecular Mechanism of Hepadnavirus Persistence
嗜肝DNA病毒持久性的分子机制
- 批准号:
8032520 - 财政年份:2008
- 资助金额:
$ 37.88万 - 项目类别:
相似国自然基金
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
Targeting protein arginine methylation in the 9p21.3 loss tumor microenvironment
9p21.3 缺失肿瘤微环境中的靶向蛋白精氨酸甲基化
- 批准号:
489995 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Operating Grants
The role of protein arginine methyl transferase PRMT1 on myelin development
蛋白精氨酸甲基转移酶PRMT1对髓磷脂发育的作用
- 批准号:
23K14287 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer
使用 Sepiaptein 使精氨酸代谢正常化以实现 HER2 乳腺癌的免疫刺激转变
- 批准号:
10776256 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)
精氨酸消耗联合铂类紫杉烷化疗对侵袭性变异前列腺癌 (AVPC) 的影响
- 批准号:
10715329 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
- 批准号:
10668754 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Physiological function of arginine signaling:macropinocytosisand tumor immune evasion
精氨酸信号的生理功能:巨胞饮作用与肿瘤免疫逃避
- 批准号:
23H03317 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Targeting protein arginine methylation in the 9p21.3 loss tumor microenvironment
9p21.3 缺失肿瘤微环境中的靶向蛋白精氨酸甲基化
- 批准号:
498862 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Operating Grants
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Arginine methylation of the RNA helicase DDX5 in the regulation of RNA/DNA hybrids during the DNA damage response.
RNA 解旋酶 DDX5 的精氨酸甲基化在 DNA 损伤反应期间调节 RNA/DNA 杂交体中的作用。
- 批准号:
487619 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Operating Grants
Regulation of and Target Recognition by Protein Arginine Methyltransferase 1 (PRMT1)
蛋白质精氨酸甲基转移酶 1 (PRMT1) 的调节和目标识别
- 批准号:
10653465 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别: